Matches 1 - 50 out of 229 1 2 3 4 5 >
Match Document Document Title
7384775 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof  
The present invention relates to newly identified open reading frames comprised within the genomic nucleotide sequence of Streptococcus pneumoniae , wherein the open reading frames encode...
7348015 Antigen modified cancer cell vaccines for cancer therapy  
Disclosed are methods for treating cancers, particularly tumorigenic types. Cancer cells are modified to express highly immunogenic antigens so that the cells will generate a defensive response in...
7338786 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics  
The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies...
7335368 BVH-A2 and BVH-A3 antigens of group B Streptococcus  
Group B streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and/or therapy of streptococcal infection in...
7332173 Group A streptococcal polysaccharide immunogenic compositions and methods  
This invention provides a novel immunogenic composition and vaccine, processes for producing them and methods for immunization against infections and disease caused by group A Streptococci. The...
7323175 Immunogenicity of glucan binding protein  
Immunogenic compositions and subunit vaccines for dental caries are described which comprise peptide subunits of glucan binding protein-B and peptide subunits of glucan binding protein-B in...
7316910 Rapid test for hemolytic streptococcus  
A reagent for the detection of an extracellular enzymatically active protein produced by a beta-hemolytic streptococcus bacteria found in a host biological fluid includes a proteinaceous substrate...
7270827 Multivalent streptococcal vaccine compositions and methods for use  
Compositions and methods for making and using therapeutic formulations of multivalent hybrid polypeptides comprising immunogenic peptides of M proteins from various different serotypes of group A...
7258992 Immunization of dairy cattle with chimeric GapC protein against Streptococcus infection  
The recombinant production of Gap4, a chimeric GapC plasmin binding protein comprising the entire amino acid sequence of the Streptococcus dysgalactiae GapC protein in addition to unique amino...
7256265 Streptococcal C5a peptidase vaccine  
Novel vaccines for use against β-hemolytic Streptococcus colonization or infection are disclosed. The vaccines contain an immunogenic amount of a variant of streptococcal C5 a peptidase (SCP)....
7255867 Vaccine  
Effective stimulation of immune responses is achieved through the use of a group A streptococcal antigen combined with proteosome adjuvant. The compositions are provided in particular for...
7247308 Streptococcus pyogenes antigens  
The present invention relates to antigens, more particularly an antigen of Streptococcus pygenes (also called group A Streptococcus (GAS)) bacterial pathogen which is useful as vaccine...
7235243 Immunological combination compositions and methods  
Immununological compositions and methods for making and using them. The compositions contain at least one antigen and at least one lipoprotein and optionally an adjuvant. The lipoprotein can itself...
7220415 Vaccine composition  
A polypeptide is described herein which comprises (a) the sequence of SEQ ID No. 2, (b) a variant of (a) which is capable of generating a protective immune response to S. pyogenes , or (c) a...
7204993 Streptococcus agalactiae vaccine  
A composition prepared from intact killed cells of isolated β-hemolytic Streptococcus agalactiae and a concentrated extract of a culture of β-hemolytic Streptococcus agalactiae , is effective...
7189404 Strain selection of pneumococcal surface proteins  
The present invention relates to vaccine composition(s) comprising at least two PspAs from strains selected from at least one family, the family being defined by PspAs from strains belonging to the...
7189398 Broad spectrum pyrogenic exotoxins antagonists and vaccines  
The invention relates to peptides having an amino acid sequence substantially homologous to an amino sequence of a domain of a pyrogenic exotoxin, which domain forms a central turn in the exotoxin...
7163682 Glucan binding protein and glucosyltransferase immunogens  
Immunogenic compositions and subunit vaccines for dental caries are described which comprise peptide subunits of glucan binding protein-B and peptide subunits of glucan binding protein-B in...
7151171 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics  
The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies...
7147857 Methods for treating high somatic cell counts  
The present invention provides methods for treating an animal having a high somatic cell count. The methods include administering compositions including siderophore receptor polypeptides and porins...
7138125 Methods for treating an animal for low milk production  
The present invention provides methods for treating an animal for low milk production. The methods include administering compositions including siderophore receptor polypeptides and porins from...
7135560 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics  
The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies...
7132107 Streptococcus pneumoniae proteins and vaccines  
The present invention relates to novel immunogenic polypeptides, and fragments thereof, and vaccines for the prevention and treatment of pneumococcal infection, especially by Streptococcus...
7129340 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics  
The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies...
7129339 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics  
The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies...
7128920 metRS2  
The invention provides metRS2 polypeptides and polynucleotides encoding metRS2 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are preferred...
7128919 Group B streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof  
This invention provides isolated nucleic acids encoding polypeptides comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides. The invention provides nucleic acids...
7128918 Streptococcus antigens  
Streptococcus proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus ...
7125548 Streptococcus suis vaccines and diagnostic tests  
The invention relates to Streptococcus suis infection in pigs, vaccines directed against those infections and tests for diagnosing Streptococcus suis infections. The invention provides an...
7122194 Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifs  
A vaccine composition is disclosed that comprises polypeptides and fragments of polypeptides containing histidine triad residues or coiled-coil regions, some of which polypeptides or fragments lie...
7118756 Recombinant protective protein from Streptococcus pneumoniae  
The present invention discloses amino acid sequences and nucleic acid sequences relating to a Streptococcus Pneumoniae surface associated Pneumo Protective Protein (PPP) having a molecular weight...
7115731 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics  
The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies...
7109006 Virulence of Streptococci  
The invention relates to the field of diagnosis of and vaccination against Streptococcal infections and to the detection of virulence markers of Streptococci. The invention discloses a method for...
7101562 Conjugate vaccines for the prevention of dental caries  
The present invention provides glucan-based compositions and methods for stimulating an immune response against mutans streptococci components and vaccines and methods for the treatment and...
7087740 Kits for use in detecting resistance to streptogramin A and related compounds  
A kit for use in detecting a bacterium having resistance to streptogramin A and related compounds is provided. A kit for use in detecting a bacterium harboring at least one polynucleotide encoding...
7087235 Fusion protein of streptococcal pyrogenic exotoxins  
The present invention relates to genetically attenuated superantigen toxin vaccines altered such that superantigen attributes are absent, however the superantigen is effectively recognized and an...
7074416 Antigen of hybrid M protein and carrier for group A streptococcal vaccine  
Recombinant hybrid streptococcal M protein antigens are provided which elicit protective antibodies against Group A streptococci and prevent rheumatic fever. Recombinant hybrid genes which encode...
7074415 Streptococcus antigens  
Streptococcus polypeptides and polynucleotides encoding them are disclosed. The polypeptides may be useful vaccine components for the prophylaxis or therapy of streptococcus infection in...
7067639 Method to provide bacterial ghosts provided with antigens  
Methods for improving binding of a proteinaceous substance to cell-wall material of a Gram-positive bacterium are disclosed. The proteinaceous substance includes an AcmA cell-wall binding domain,...
7063850 Protective antigen of group A Streptococci  
The present invention provides the discovery of a new Streptococcus protective antigen (herein designated Spa) which has been identified and isolated from Streptococci. Spa is a surface antigen...
7060277 Broad spectrum antagonists and vaccines directed against pyrogenic exotoxins  
The invention relates to peptides comprising an amino acid sequence homologous to the amino sequence of a fragment of a pyrogenic exotoxin, and functional derivatives of said peptides, capable of...
7056697 FabK variant  
The invention provides FabK polypeptides and polynucleotides encoding FabK polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for...
7056517 Glucosyltransferase immunogens  
Vaccine compositions and immunogenic compositions are described which are glucosyltransferase subunit vaccines for dental caries and which contain at least one peptide which corresponds to a...
7056510 Streptococcus pneumoniae SP036 polynucleotides, polypeptides, antigens and vaccines  
The present invention relates to novel vaccines for the prevention or attenuation of infection by Streptococcus pneunoniae. The invention further relates to isolated nucleic acid molecules...
7049419 Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor  
Disclosed and claimed are: epitopic regions of Pneumococcal Surface Protein C or “PspC”, different clades of PspC, isolated and/or purified nucleic acid molecules such as DNA encoding a...
7045132 Streptococcus pneumoniae 37-kDa surface adhesin a protein  
The invention provides a nucleic acid encoding the 37-kDa protein from Streptococcus pneumoniae . Also provided are isolated nucleic acids comprising a unique fragment of at least 10 nucleotides...
7018637 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines  
Multivalent immunogenic molecules comprise a carrier molecule containing at least one functional T-cell epitope and multiple different carbohydrate fragments each linker to the carrier molecule and...
6994997 Gram positive bacteria deprived of HtrA protease activity and their uses  
The invention concerns bacteria strains, obtained from gram-positive bacteria whereof the genome size is not more than 3.2 Mb, and wherein the HtrA surface protease is inactive. Said strains are...
6936259 CAMP factor of Streptococcus uberis  
The CAMP factor gene of Streptococcus uberis ( S. uberis ) is described, as well as the recombinant production of CAMP factor therefrom. Also disclosed are chimeric CAMP factor constructs,...
6936252 Streptococcus pneumoniae proteins and nucleic acid molecules  
Novel protein antigens from Streptococcus pneumoniae are disclosed, together with nucliec acid sequences encoding them. Their use in vaccines and in screening methods is also described.
Matches 1 - 50 out of 229 1 2 3 4 5 >